<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font18 { font-size : 18; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font28 { font-size : 28; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font28">and </span>
   <span class="font21">with </span>
   <span class="font20">patients </span>
   <span class="font20">hepatitis </span>
   <span class="font18">for </span>
   <span class="font17">HBV </span>
   <span class="font14">are </span>
   <span class="font14">[]. </span>
   <span class="font14">reactivation </span>
   <span class="font14">vaccination </span>
   <span class="font14">IBD </span>
   <span class="font13">who </span>
   <span class="font13">virus </span>
   <span class="font13">should </span>
   <span class="font12">The </span>
   <span class="font12">after </span>
   <span class="font12">risk </span>
   <span class="font12">immunosuppressive </span>
   <span class="font12">infection </span>
   <span class="font12">was </span>
   <span class="font12">management </span>
   <span class="font12">therapy </span>
   <span class="font12">{background </span>
   <span class="font11">inflammatory </span>
   <span class="font11">not </span>
   <span class="font11">response </span>
   <span class="font11">that </span>
   <span class="font11">vaccine </span>
   <span class="font11">Association </span>
   <span class="font11">HAV </span>
   <span class="font11">chronic </span>
   <span class="font11">bowel </span>
   <span class="font11">strongly </span>
   <span class="font11">those </span>
   <span class="font11">[,]. </span>
   <span class="font11">antibody </span>
   <span class="font11">may </span>
   <span class="font11">HCV </span>
   <span class="font11">Study </span>
   <span class="font11">agree </span>
   <span class="font11">disease </span>
   <span class="font11">margin </span>
   <span class="font11">disagree </span>
   <span class="font11">dose </span>
   <span class="font11">have </span>
   <span class="font11">were </span>
   <span class="font11">{border-style </span>
   <span class="font11">recommended </span>
   <span class="font11">than </span>
   <span class="font11">viral </span>
   <span class="font11">.%, </span>
   <span class="font11">Korean </span>
   <span class="font11">clinical </span>
   <span class="font11">guidelines </span>
   <span class="font11">low </span>
   <span class="font11">px;} </span>
   <span class="font11">treatment </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">Dis </span>
   <span class="font11">Hepatol </span>
   <span class="font11">antiviral </span>
   <span class="font11">has </span>
   <span class="font11">months </span>
   <span class="font11">positive </span>
   <span class="font11">prophylaxis </span>
   <span class="font11">recommendations </span>
   <span class="font11">anti-HBc </span>
   <span class="font11">anti-HBs </span>
   <span class="font11">but </span>
   <span class="font11">high </span>
   <span class="font11">immune </span>
   <span class="font11">prevention </span>
   <span class="font11">receiving </span>
   <span class="font11">treated </span>
   <span class="font11">administered </span>
   <span class="font11">booster </span>
   <span class="font11">during </span>
   <span class="font11">practice </span>
   <span class="font11">prevalence </span>
   <span class="font11">rate </span>
   <span class="font10">DNA </span>
   <span class="font10">HBsAg-negative </span>
   <span class="font10">been </span>
   <span class="font10">plus </span>
   <span class="font10">Gastroenterol </span>
   <span class="font10">HBsAg-positive </span>
   <span class="font10">can </span>
   <span class="font10">from </span>
   <span class="font10">level </span>
   <span class="font10">liver </span>
   <span class="font10">which </span>
   <span class="font10">HBsAg </span>
   <span class="font10">However, </span>
   <span class="font10">IgG </span>
   <span class="font10">Korea </span>
   <span class="font10">all </span>
   <span class="font10">collab: </span>
   <span class="font10">effect </span>
   <span class="font10">European </span>
   <span class="font10">al. </span>
   <span class="font10">evidence </span>
   <span class="font10">recommendation, </span>
   <span class="font10">seroprotection </span>
   <span class="font10">Level </span>
   <span class="font10">Liver </span>
   <span class="font10">agreement: </span>
   <span class="font10">anti-HAV </span>
   <span class="font10">associated </span>
   <span class="font10">because </span>
   <span class="font10">guideline </span>
   <span class="font10">immunosuppression </span>
   <span class="font10">more </span>
   <span class="font10">rheumatic </span>
   <span class="font10">testing </span>
   <span class="font10">uncertain </span>
   <span class="font10">vaccines </span>
   <span class="font10">(strong </span>
   <span class="font10">Clin </span>
   <span class="font10">IBD, </span>
   <span class="font10">IBD. </span>
   <span class="font10">Korea, </span>
   <span class="font10">Korea[], </span>
   <span class="font10">Statement </span>
   <span class="font10">before </span>
   <span class="font10">compared </span>
   <span class="font10">endemicity </span>
   <span class="font10">factors </span>
   <span class="font10">revaccination </span>
   <span class="font10">such </span>
   <span class="font10">this </span>
   <span class="font10">titers </span>
   <span class="font10">undergoing </span>
   <span class="font10">Mol </span>
   <span class="font10">Thus, </span>
   <span class="font10">[-]. </span>
   <span class="font10">adult </span>
   <span class="font10">against </span>
   <span class="font10">agents </span>
   <span class="font10">among </span>
   <span class="font10">between </span>
   <span class="font10">cases </span>
   <span class="font10">evidence). </span>
   <span class="font10">had </span>
   <span class="font10">high-risk </span>
   <span class="font10">intermediate </span>
   <span class="font10">moderate </span>
   <span class="font10">past </span>
   <span class="font10">px; </span>
   <span class="font10">rheumatoid </span>
   <span class="font10">very </span>
   <span class="font10">when </span>
   <span class="font10">years </span>
   <span class="font10">{font-family </span>
   <span class="font10">American </span>
   <span class="font10">Infect </span>
   <span class="font10">Patients </span>
   <span class="font10">Therefore, </span>
   <span class="font10">[], </span>
   <span class="font10">acute </span>
   <span class="font10">additional </span>
   <span class="font10">al.Hepatitis </span>
   <span class="font10">also </span>
   <span class="font10">areas </span>
   <span class="font10">countries </span>
   <span class="font10">different </span>
   <span class="font10">efficacy </span>
   <span class="font10">font-size </span>
   <span class="font10">hepatitis, </span>
   <span class="font10">highly </span>
   <span class="font10">history </span>
   <span class="font10">immunity </span>
   <span class="font10">infections </span>
   <span class="font10">lower </span>
   <span class="font10">monitored </span>
   <span class="font10">most </span>
   <span class="font10">one </span>
   <span class="font10">over </span>
   <span class="font10">protective </span>
   <span class="font10">reported </span>
   <span class="font10">require </span>
   <span class="font10">seroconversion </span>
   <span class="font10">standard </span>
   <span class="font10">study </span>
   <span class="font10">their </span>
   <span class="font10">therapy. </span>
   <span class="font10">they </span>
   <span class="font10">vaccination, </span>
   <span class="font10">ALT </span>
   <span class="font10">Bowel </span>
   <span class="font10">Disease </span>
   <span class="font10">Diseases </span>
   <span class="font10">Guidelines </span>
   <span class="font10">HBsAg, </span>
   <span class="font10">Intestinal </span>
   <span class="font10">Journal </span>
   <span class="font10">Long-term </span>
   <span class="font10">Res </span>
   <span class="font10">Rheumatology </span>
   <span class="font10">TNF-Î± </span>
   <span class="font10">United </span>
   <span class="font10">administration </span>
   <span class="font10">and/or </span>
   <span class="font10">anti-HBc-positive </span>
   <span class="font10">based </span>
   <span class="font10">biologic </span>
   <span class="font10">cell </span>
   <span class="font10">children </span>
   <span class="font10">corticosteroids </span>
   <span class="font10">demonstrated </span>
   <span class="font10">diagnosis </span>
   <span class="font10">diseases </span>
   <span class="font10">double; </span>
   <span class="font10">immunization </span>
   <span class="font10">immunomodulators </span>
   <span class="font10">immunosuppressed </span>
   <span class="font10">inactivated </span>
   <span class="font10">infection: </span>
   <span class="font10">least </span>
   <span class="font10">members </span>
   <span class="font10">necrosis </span>
   <span class="font10">negative </span>
   <span class="font10">primary </span>
   <span class="font10">quality </span>
   <span class="font10">review </span>
   <span class="font10">safety </span>
   <span class="font10">serum </span>
   <span class="font10">time </span>
   <span class="font10">transmission </span>
   <span class="font10">using </span>
   <span class="font10">vaccination. </span>
   <span class="font10">weeks) </span>
   <span class="font10">&amp;lt; </span>
   <span class="font10">Antiviral </span>
   <span class="font10">Asia, </span>
   <span class="font10">DNA, </span>
   <span class="font10">Med </span>
   <span class="font10">Park </span>
   <span class="font10">Research </span>
   <span class="font10">South </span>
   <span class="font10">Table </span>
   <span class="font10">Vaccination </span>
   <span class="font10">Virol </span>
   <span class="font10">anti-TNF, </span>
   <span class="font10">arthritis </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">both </span>
   <span class="font10">classified </span>
   <span class="font10">committee </span>
   <span class="font10">course </span>
   <span class="font10">diagnosis, </span>
   <span class="font10">each </span>
   <span class="font10">estimate </span>
   <span class="font10">every </span>
   <span class="font10">following </span>
   <span class="font10">given </span>
   <span class="font10">including </span>
   <span class="font10">increase </span>
   <span class="font10">infliximab </span>
   <span class="font10">key </span>
   <span class="font10">lamivudine </span>
   <span class="font10">opportunistic </span>
   <span class="font10">patients, </span>
   <span class="font10">preventive </span>
   <span class="font10">previous </span>
   <span class="font10">protection </span>
   <span class="font10">recommend </span>
   <span class="font10">serology </span>
   <span class="font10">solid; </span>
   <span class="font10">some </span>
   <span class="font10">systematic </span>
   <span class="font10">therapy, </span>
   <span class="font10">these </span>
   <span class="font10">will </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">%â% </span>
   <span class="font10">(HBsAg, </span>
   <span class="font10">(KASL) </span>
   <span class="font10">(prednisone </span>
   <span class="font10">According </span>
   <span class="font10">Africa </span>
   <span class="font10">Although </span>
   <span class="font10">CI, </span>
   <span class="font10">Centers </span>
   <span class="font10">College </span>
   <span class="font10">Control </span>
   <span class="font10">Europe </span>
   <span class="font10">Furthermore, </span>
   <span class="font10">HAV, </span>
   <span class="font10">HBsAg-positive, </span>
   <span class="font10">KASL </span>
   <span class="font10">Rheum </span>
   <span class="font10">Rheumatol </span>
   <span class="font10">Society </span>
   <span class="font10">States </span>
   <span class="font10">USA </span>
   <span class="font10">WHO </span>
   <span class="font10">Western </span>
   <span class="font10">about </span>
   <span class="font10">according </span>
   <span class="font10">achieved </span>
   <span class="font10">adults </span>
   <span class="font10">anti-TNF-Î± </span>
   <span class="font10">antigen </span>
   <span class="font10">autoimmune </span>
   <span class="font10">bold </span>
   <span class="font10">cancer </span>
   <span class="font10">care </span>
   <span class="font10">chemotherapy: </span>
   <span class="font10">consensus </span>
   <span class="font10">considered </span>
   <span class="font10">contrast, </span>
   <span class="font10">core </span>
   <span class="font10">courier; </span>
   <span class="font10">current </span>
   <span class="font10">cycle </span>
   <span class="font10">cytotoxic </span>
   <span class="font10">does </span>
   <span class="font10">doses </span>
   <span class="font10">drug </span>
   <span class="font10">em; </span>
   <span class="font10">endemic </span>
   <span class="font10">epidemiological </span>
   <span class="font10">especially </span>
   <span class="font10">even </span>
   <span class="font10">exposure </span>
   <span class="font10">factor </span>
   <span class="font10">food </span>
   <span class="font10">group </span>
   <span class="font10">groups </span>
   <span class="font10">guideline. </span>
   <span class="font10">guidelines, </span>
   <span class="font10">host </span>
   <span class="font10">immunisation </span>
   <span class="font10">immunocompromised </span>
   <span class="font10">included </span>
   <span class="font10">increased </span>
   <span class="font10">infection, </span>
   <span class="font10">inhibitors </span>
   <span class="font10">into </span>
   <span class="font10">involving </span>
   <span class="font10">less </span>
   <span class="font10">levels </span>
   <span class="font10">likely </span>
   <span class="font10">mg/day, </span>
   <span class="font10">monitoring </span>
   <span class="font10">months, </span>
   <span class="font10">need </span>
   <span class="font10">only </span>
   <span class="font10">oral </span>
   <span class="font10">people </span>
   <span class="font10">population </span>
   <span class="font10">positivity </span>
   <span class="font10">potent </span>
   <span class="font10">potential </span>
   <span class="font10">prevention, </span>
   <span class="font10">pt;} </span>
   <span class="font10">published </span>
   <span class="font10">questions </span>
   <span class="font10">rates </span>
   <span class="font10">reactivation. </span>
   <span class="font10">receive </span>
   <span class="font10">recommendation </span>
   <span class="font10">routine </span>
   <span class="font10">seroreversion </span>
   <span class="font10">several </span>
   <span class="font10">significantly </span>
   <span class="font10">starting </span>
   <span class="font10">stem </span>
   <span class="font10">tested </span>
   <span class="font10">through </span>
   <span class="font10">titer </span>
   <span class="font10">transmitted </span>
   <span class="font10">transplantation </span>
   <span class="font10">true </span>
   <span class="font10">use </span>
   <span class="font10">vaccinations </span>
   <span class="font10">virological </span>
   <span class="font10">where </span>
   <span class="font10">whether </span>
   <span class="font10">while </span>
  </p>
 </body>
</html>
